Skip to main content
Site Logo

Download QR

Open Free Demat Account!

Join Our 9 Lakh Customers

+91
Headphone
HomeStocksAurobindo Pharma Ltd
Aurobindo Pharma Ltd

Aurobindo Pharma Ltd

Symbol:AUROPHARMA
Mid Cap
LTP1679.8
+11.4 (0.68%)
No chart data available for selected period

Fundamentals Ratios

Key Valuation Metrics

Market Cap₹96,401.69 Cr
P/E Ratio25.98
P/B Ratio4.24
Industry Ratio37.96
ROE9.25%
EPS (TTM)₹64.49
Dividend Yield0.24%
Book Value₹394.82
Face Value₹1
Sector P/E37.96
Outstanding Shares57.54 Cr
Beta0.36
Market Cap Type- -

Financial Statements

ParticularsMAR 2025MAR 2024MAR 2023MAR 2022
Sales Turnover31,723.7329,001.8724,855.3823,455.49
Other Income621.85557.38290.59436.38
Total Revenue32,943.2130,505.4225,555.6523,075.19
Total Expenditure25,770.2624,314.0621,558.0918,527.29
Operating Profit7,172.956,191.363,997.564,547.9
Interest457.24289.71140.4848.64
Gross Profit6,715.715,901.653,857.084,499.26
Depreciation1,649.421,521.661,244.581,126.52
Profit Before Tax5,066.294,379.992,612.53,372.74
Tax1,699.981,777.541,071.48662.82
Net Profit3,483.573,168.971,927.652,647.11

About

Managing Director- -
Auditor NameDeloitte Haskins & Sells
Founded1986
Parent OrganizationAurobindo Pharma Ltd

Price Summary

Open

₹1,666.7

Prev Close

₹1,668.4

Today's High

₹1,681.4

Today's Low

₹1,655.5

52W High₹1,717
52W Low₹1,061.3
Volume4,94,251
Traded ValueN/A

Shareholding Pattern

Foreign Promoters and Groups
Indian Promoters and Groups
Non-Promoter Institutions
Non-Promoter Non-Institutions

Data as per latest exchange filings*

Frequently Asked Questions

Common questions about this stock, answered from live data

As of 11 Sept 2026, 3:30 pm, the share price of Aurobindo Pharma Ltd (AUROPHARMA) is ₹1,679.8 on NSE and BSE.

Disclaimer: The FAQs above are generated based on historical and real-time market data provided by exchanges. This information is for educational purposes only and does not constitute financial advice, buy/sell recommendations, or price targets. Investment in the securities market is subject to market risks. Read all related documents carefully before investing.